Annual Interest Expense
$6.87 M
+$3.17 M+85.38%
31 December 2023
Summary:
Rigel Pharmaceuticals annual interest expense is currently $6.87 million, with the most recent change of +$3.17 million (+85.38%) on 31 December 2023. During the last 3 years, it has risen by +$5.52 million (+407.91%). RIGL annual interest expense is now at all-time high.RIGL Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$2.06 M
+$31.00 K+1.53%
30 September 2024
Summary:
Rigel Pharmaceuticals quarterly interest expense is currently $2.06 million, with the most recent change of +$31.00 thousand (+1.53%) on 30 September 2024. Over the past year, it has increased by +$161.00 thousand (+8.48%). RIGL quarterly interest expense is now at all-time high.RIGL Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$7.87 M
+$161.00 K+2.09%
30 September 2024
Summary:
Rigel Pharmaceuticals TTM interest expense is currently $7.87 million, with the most recent change of +$161.00 thousand (+2.09%) on 30 September 2024. Over the past year, it has increased by +$1.80 million (+29.61%). RIGL TTM interest expense is now at all-time high.RIGL TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RIGL Interest Expense Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +85.4% | +8.5% | +29.6% |
3 y3 years | +407.9% | +56.4% | +97.2% |
5 y5 years | +100.0% | +10000.0% | +10000.0% |
RIGL Interest Expense High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +407.9% | at high | +262.0% | at high | +112.4% |
5 y | 5 years | at high | at high | >+9999.0% | at high | >+9999.0% | |
alltime | all time | at high | at high | at high |
Rigel Pharmaceuticals Interest Expense History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $2.06 M(+1.5%) | $7.87 M(+2.1%) |
June 2024 | - | $2.03 M(+8.3%) | $7.71 M(+2.2%) |
Mar 2024 | - | $1.87 M(-1.7%) | $7.54 M(+9.7%) |
Dec 2023 | $6.87 M(+85.4%) | $1.91 M(+0.4%) | $6.87 M(+13.2%) |
Sept 2023 | - | $1.90 M(+2.0%) | $6.07 M(+21.5%) |
June 2023 | - | $1.86 M(+54.7%) | $5.00 M(+34.9%) |
Mar 2023 | - | $1.20 M(+8.8%) | $3.71 M(-0.0%) |
Dec 2022 | $3.71 M(-23.7%) | $1.11 M(+34.0%) | $3.71 M(-4.9%) |
Sept 2022 | - | $826.00 K(+45.2%) | $3.90 M(-11.2%) |
June 2022 | - | $569.00 K(-52.8%) | $4.39 M(-21.3%) |
Mar 2022 | - | $1.21 M(-7.2%) | $5.58 M(+14.8%) |
Dec 2021 | $4.86 M(+259.2%) | $1.30 M(-1.4%) | $4.86 M(+21.8%) |
Sept 2021 | - | $1.32 M(-25.1%) | $3.99 M(+28.6%) |
June 2021 | - | $1.76 M(+262.7%) | $3.10 M(+82.9%) |
Mar 2021 | - | $485.00 K(+13.1%) | $1.70 M(+25.4%) |
Dec 2020 | $1.35 M(+303.9%) | $429.00 K(0.0%) | $1.35 M(+8.2%) |
Sept 2020 | - | $429.00 K(+21.5%) | $1.25 M(+50.7%) |
June 2020 | - | $353.00 K(+148.6%) | $830.00 K(+74.0%) |
Mar 2020 | - | $142.00 K(-56.6%) | $477.00 K(+42.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2019 | $335.00 K(>+9900.0%) | $327.00 K(+3987.5%) | $335.00 K(+4087.5%) |
Sept 2019 | - | $8000.00(>+9900.0%) | $8000.00(>+9900.0%) |
June 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
Mar 2019 | - | $0.00(0.0%) | $0.00(0.0%) |
Dec 2018 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
Sept 2018 | - | $0.00(-100.0%) | $0.00(-100.0%) |
Dec 2017 | $0.00(-100.0%) | - | - |
Dec 2011 | $25.00 K(-72.5%) | $3000.00(-25.0%) | $25.00 K(-41.9%) |
Sept 2011 | - | $4000.00(-42.9%) | $43.00 K(-20.4%) |
June 2011 | - | $7000.00(-36.4%) | $54.00 K(-25.0%) |
Mar 2011 | - | $11.00 K(-47.6%) | $72.00 K(-20.9%) |
Dec 2010 | $91.00 K(-55.2%) | $21.00 K(+40.0%) | $91.00 K(-15.0%) |
Sept 2010 | - | $15.00 K(-40.0%) | $107.00 K(-21.3%) |
June 2010 | - | $25.00 K(-16.7%) | $136.00 K(-24.4%) |
Mar 2010 | - | $30.00 K(-18.9%) | $180.00 K(-11.3%) |
Dec 2009 | $203.00 K(+26.9%) | $37.00 K(-15.9%) | $203.00 K(+22.3%) |
Sept 2009 | - | $44.00 K(-36.2%) | $166.00 K(+36.1%) |
June 2009 | - | $69.00 K(+30.2%) | $122.00 K(+130.2%) |
Mar 2009 | - | $53.00 K | $53.00 K |
Dec 2008 | $160.00 K | - | - |
FAQ
- What is Rigel Pharmaceuticals annual interest expense?
- What is the all time high annual interest expense for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals annual interest expense year-on-year change?
- What is Rigel Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals quarterly interest expense year-on-year change?
- What is Rigel Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Rigel Pharmaceuticals?
- What is Rigel Pharmaceuticals TTM interest expense year-on-year change?
What is Rigel Pharmaceuticals annual interest expense?
The current annual interest expense of RIGL is $6.87 M
What is the all time high annual interest expense for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high annual interest expense is $6.87 M
What is Rigel Pharmaceuticals annual interest expense year-on-year change?
Over the past year, RIGL annual interest expense has changed by +$3.17 M (+85.38%)
What is Rigel Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of RIGL is $2.06 M
What is the all time high quarterly interest expense for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high quarterly interest expense is $2.06 M
What is Rigel Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, RIGL quarterly interest expense has changed by +$161.00 K (+8.48%)
What is Rigel Pharmaceuticals TTM interest expense?
The current TTM interest expense of RIGL is $7.87 M
What is the all time high TTM interest expense for Rigel Pharmaceuticals?
Rigel Pharmaceuticals all-time high TTM interest expense is $7.87 M
What is Rigel Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, RIGL TTM interest expense has changed by +$1.80 M (+29.61%)